ReviewFrontiers in pharmacology2026
Toward oral nanomaterial-based drug delivery systems for hepatocellular carcinoma therapy: evidence mapping, route-specific validation, and translational challenges.
Yang Fu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.